Home / Mometasone / Czechia
CZ ATC R01AD09 · updated 2 Nov 2026
Mometasone shortage in Czechia
Is there a Mometasone shortage in Czechia?
Yes. As of 2 Nov 2026, 1 Mometasone product is reported short in Czechia, the first since 10 Jul 2026. The company estimate for the return is 13 Nov 2026. Main reason: regulatory or licensing.
Also short in Canada, Italy, Sweden, New Zealand. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | METSANDIA 50MCG/DÁV 50MCG/DÁV NAS SPR SUS 120DÁV | Zentiva, k.s., Praha | 10 Jul 2026 | 13 Nov 2026 | Regulatory or licensing Procesní-registrační důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.